Cargando…

Methodology of a Novel Risk Stratification Algorithm for Patients with Multiple Myeloma in the Relapsed Setting

INTRODUCTION: Risk stratification tools provide valuable information to inform treatment decisions. Existing algorithms for patients with multiple myeloma (MM) were based on patients with newly diagnosed disease, and these have not been validated in the relapsed setting or in routine clinical practi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bouwmeester, Walter, Briggs, Andrew, van Hout, Ben, Hájek, Roman, Gonzalez-McQuire, Sebastian, Campioni, Marco, DeCosta, Lucy, Brozova, Lucie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359995/ https://www.ncbi.nlm.nih.gov/pubmed/32699987 http://dx.doi.org/10.1007/s40487-019-00100-5

Ejemplares similares

Novel risk stratification algorithm for estimating the risk of death in patients with relapsed multiple myeloma: external validation in a retrospective chart review
por: Hájek, Roman, et al.
Publicado: (2020)

Development and validation of a novel risk stratification algorithm for relapsed multiple myeloma
por: Hájek, Roman, et al.
Publicado: (2019)

Methodology and results of real-world cost-effectiveness of carfilzomib in combination with lenalidomide and dexamethasone in relapsed multiple myeloma using registry data
por: Campioni, M., et al.
Publicado: (2019)

Development of an Initial Conceptual Model of Multiple Myeloma to Support Clinical and Health Economics Decision Making
por: Gonzalez-McQuire, Sebastian, et al.
Publicado: (2019)

Long-term Outcomes in Patients With Multiple Myeloma: A Retrospective Analysis of the Dutch Population-based HAematological Registry for Observational Studies (PHAROS)
por: Verelst, Silvia G.R., et al.
Publicado: (2018)

Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies
por: Radocha, Jakub, et al.
Publicado: (2018)

P24: EXPERT PERSPECTIVES OF UNMET NEED IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WHO RECEIVE LENALIDOMIDE-SPARING REGIMENS IN EUROPE
por: Mateos, M, et al.
Publicado: (2022)

Reframing the Value of Treatments for Relapsed/Refractory Multiple Myeloma
por: Ailawadhi, Sikander, et al.
Publicado: (2018)

Centrosome associated genes pattern for risk sub-stratification in multiple myeloma
por: Kryukov, Fedor, et al.
Publicado: (2016)

Understanding mortality in multiple myeloma: Findings of a European retrospective chart review
por: Mohty, Mohamad, et al.
Publicado: (2019)

P15: EVOLUTION OF MULTIPLE MYELOMA TREATMENT PATTERNS FROM 2015 THROUGH 2019: REAL-WORLD EVIDENCE FROM A EUROPEAN DATABASE STUDY
por: Oriol Rocafiguera, A, et al.
Publicado: (2022)

Selective Metaphor Impairments After Left, Not Right, Hemisphere Injury
por: Cardillo, Eileen R., et al.
Publicado: (2018)

Dynamics of tumor‐specific cfDNA in response to therapy in multiple myeloma patients
por: Vrabel, David, et al.
Publicado: (2019)

Multiple myeloma: patient outcomes in real‐world practice
por: Yong, Kwee, et al.
Publicado: (2016)

Erratum to: Pharmacological interventions for challenging behaviour in children with intellectual disabilities: a systematic review and meta-analysis
por: McQuire, Cheryl, et al.
Publicado: (2016)

Pharmacological interventions for challenging behaviour in children with intellectual disabilities: a systematic review and meta-analysis
por: McQuire, Cheryl, et al.
Publicado: (2015)

Forecasting the 2021 local burden of population alcohol‐related harms using Bayesian structural time–series
por: McQuire, Cheryl, et al.
Publicado: (2019)

The causal web of foetal alcohol spectrum disorders: a review and causal diagram
por: McQuire, Cheryl, et al.
Publicado: (2019)

Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice
por: Minarik, Jiri, et al.
Publicado: (2021)

Identification of patients at high risk of secondary extramedullary multiple myeloma development
por: Stork, Martin, et al.
Publicado: (2021)

International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)
por: Mateos, María-Victoria, et al.
Publicado: (2020)

Flying under the radar: figurative language impairments in focal lesion patients
por: Ianni, Geena R., et al.
Publicado: (2014)

T203. RELEVANT CLOZAPINE BLOOD LEVELS USING A POINT OF CARE TEST (POCT)
por: Kelly, Deanna, et al.
Publicado: (2020)

Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma
por: Mithraprabhu, Sridurga, et al.
Publicado: (2023)

(18)FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation
por: Lapa, Constantin, et al.
Publicado: (2014)

Bat3 deficiency accelerates the degradation of Hsp70-2/HspA2 during spermatogenesis
por: Sasaki, Toru, et al.
Publicado: (2008)

The Neural Basis of Metaphor Comprehension: Evidence from Left Hemisphere Degeneration
por: Klooster, Nathaniel, et al.
Publicado: (2020)

Plasmacytoid Dendritic Cells in Patients with MGUS and Multiple Myeloma
por: Knight, Andrea, et al.
Publicado: (2021)

Conceptualising natural and quasi experiments in public health
por: de Vocht, Frank, et al.
Publicado: (2021)

Depth of response and response kinetics of isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma
por: Martin, Thomas, et al.
Publicado: (2022)

Multiple Myeloma: Risk Stratification and Toxicity Management
por: Richards, Tiffany, et al.
Publicado: (2018)

Risk Stratification and Treatment in Smoldering Multiple Myeloma
por: Lussier, Tyler, et al.
Publicado: (2021)

Health-related quality of life in the ENDEAVOR study: carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed/refractory multiple myeloma
por: Ludwig, Heinz, et al.
Publicado: (2019)

Association between cigarette smoking status and voting intentions: Cross sectional surveys in England 2015-2020
por: Cox, Sharon, et al.
Publicado: (2021)

Increased T Regulatory Cells Are Associated with Adverse Clinical Features and Predict Progression in Multiple Myeloma
por: Muthu Raja, Karthick Raja, et al.
Publicado: (2012)

The use of the World Guidelines for Falls Prevention and Management’s risk stratification algorithm in predicting falls in The Irish Longitudinal Study on Ageing (TILDA)
por: Hartley, Peter, et al.
Publicado: (2023)

A phase 2 study of ibrutinib in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma
por: Hajek, Roman, et al.
Publicado: (2020)

Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis
por: Stork, Martin, et al.
Publicado: (2023)

Pericardial relapse of multiple myeloma
por: Jamison, Lee S, et al.
Publicado: (2020)

Screening prevalence of fetal alcohol spectrum disorders in a region of the United Kingdom: A population-based birth-cohort study
por: McQuire, Cheryl, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2srovmkuia90mnfkgn4u27lbo9